Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
Transrectal ultrasound-guided prostate biopsies in patients taking aspirin for cardiovascular disease: A meta-analysis
Transfusion and Apheresis Science, Volume 45, No. 3, Year 2011
Notification
URL copied to clipboard!
Description
Introduction: The management of anti-platelet therapy in the peri-operative period is a source of great concern. The dilemma is between whether to stop these agents peri-operatively in order to reduce the risk of bleeding complications, or to continue them in order not to compromise the protection they afford against the risk of cardiovascular events. Materials and methods: The aim of this systematic review and meta-analysis was to understand whether continued aspirin therapy is a risk factor for bleeding complications after ultrasound-guided biopsy of the prostate. A bibliographic search covering the period from January 1990 to May 2011 was conducted in PubMed, MEDLINE and EMBASE. We also included our own series in the analysis. Results: A total of 3218 participants were included. Haematuria was statistically more frequent (P=0.001) among patients taking aspirin than in the control group with an odds ratio estimate of 1.36 [1.13; 1.64]. This increased risk was, however, due to minor bleeding. The occurrence of rectal bleeding and haematospermia was not statistically increased (P=0.33 and P=0.24, respectively) in patients taking aspirin compared to in the control group with odds ratios estimate of 1.24 [0.80; 1.93] and 1.52 [0.75; 3.08], respectively. Discussion: There is limited information of the relationship between continued use of aspirin and haemorrhagic complications after transrectal ultrasound-guided biopsy of the prostate. This is the first comprehensive analysis on this topic. Conclusion: Continued use of aspirin does not increase the risk of overall bleeding or moderate and severe haematuria after prostatic biopsy, and thus stopping aspirin before such biopsies is unnecessary. © 2011 Elsevier Ltd.
Authors & Co-Authors
Carmignani, Luca
Italy, San Donato Milanese
Gruppo Ospedaliero San Donato
Bozzini, Giorgio
Italy, San Donato Milanese
Gruppo Ospedaliero San Donato
Ricci, Cristian
Italy, San Donato Milanese
Gruppo Ospedaliero San Donato
Gaeta, Maddalena M.
Italy, Pavia
Università Degli Studi Di Pavia
Pavesi, Marco
Italy, San Donato Milanese
Gruppo Ospedaliero San Donato
Statistics
Citations: 35
Authors: 5
Affiliations: 3
Identifiers
Doi:
10.1016/j.transci.2011.10.008
ISSN:
18781683
Research Areas
Noncommunicable Diseases
Study Design
Randomised Control Trial
Case-Control Study
Study Approach
Systematic review